New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
05:12 EDTUNH, CNC, WLP, HCA, AETBarron's revisits the Obamacare stocks that will be winners and losers
President Obama's re-election should help hospitals and insurers who can benefit from health-care reform. However, medical-device makers and big insurers may struggle under his "Obamacare", Barron's contends. Post election, shares of HCA (HCA) and Centene (CNC) rose amid a growing belief that profits will soar along with membership in Medicaid programs. Share prices should keep climbing over the next year. Big health insurers like Aetna (AET), WellPoint (WLP) and UnitedHealth Group (UNH) will face tough new rules governing how they do business that could squeeze future profits. Yet Obama's victory doesn't clear away all the clouds hanging over the health-care sector. To help defray the cost of giving all Americans health benefits, medical-device makers will have to start paying excise taxes next year, while drug makers must give bigger price rebates to Medicaid and Medicare patients. Barron's suggests that investors with a longer-term investment horizon may want to cast a wider net beyond hospitals and insurers to include drug makers and other companies with products or services that can bring down spiraling health-care costs. Reference Link
News For HCA;CNC;AET;WLP;UNH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
07:11 EDTHCAHCA Holdings price target raised to $105 from $88 at Cantor
Subscribe for More Information
July 30, 2015
10:00 EDTAETOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:31 EDTAETAetna upgraded to Buy from Neutral at BofA/Merrill
July 29, 2015
16:59 EDTCNCHealth Net cancels conference call, webcast
Health Net (HNT) announced that, as a result of the July 2, announcement that Health Net and Centene (CNC) approved a definitive agreement under which Centene will acquire all of the shares of Health Net in a cash and stock transaction valued at approximately $6.8B, including the assumption of approximately $500M of debt, Health Net is cancelling its previously scheduled Q2 earnings conference call and webcast. The call was previously scheduled for August 4, at 12:00 noon Eastern time. Health Net intends to issue a press release reporting the company’s financial results for Q2, as planned, before the market opens on Tuesday, August 4. The company expects to file its Quarterly Report on Form 10-Q for the quarter ended June 30 with the SEC on or about August 5.
09:12 EDTCNCCentene has reached attractive entry point, says BMO Capital
Subscribe for More Information
07:33 EDTAETHumana sees Aetna transaction closing in 2H16
Subscribe for More Information
July 28, 2015
06:11 EDTCNCCentene sees FY15 EPS $2.72-$2.82, consensus $2.79
Subscribe for More Information
06:10 EDTCNCCentene reports Q2 EPS 72c, consensus 70c
Subscribe for More Information
July 27, 2015
13:24 EDTAETRegulators to consider 'too big to fail' in health insurance reviews, CTFN says
Subscribe for More Information
10:00 EDTCNCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADT Corp. (ADT) upgraded to Buy from Neutral at Citi... AGCO (AGCO) upgraded to Neutral from Sell at Goldman... Anthem (ANTM) upgraded to Buy from Neutral at Sterne Agee CRT... BNP Paribas (BNPQY) upgraded to Buy from Neutral at Goldman... Biogen (BIIB) upgraded on valuation at Bernstein... Box (BOX) upgraded to Overweight from Sector Weight at Pacific Crest... Capital One (COF) upgraded to Buy from Outperform at CLSA... Centene (CNC) upgraded to Buy from Neutral at UBS... Chesapeake (CHK) upgraded on potential sale of assets or company at SunTrust... Cigna (CI) upgraded to Buy from Neutral at Sterne Agee CRT... Deere (DE) upgraded to Neutral from Sell at Goldman... First BanCorp (FBP) upgraded to Buy from Neutral at Guggenheim... Flotek (FTK) upgraded on stronger demand at Oppenheimer... Lear (LEA) upgraded to Buy from Hold at Deutsche Bank... Methanex (MEOH) upgraded to Outperform from Sector Perform at Scotia Howard Weil... News Corp. (NWSA) upgraded to Outperform from Neutral at Macquarie... NextEra Energy Partners (NEP) upgraded to Outperform at Wells Fargo... OFG Bancorp (OFG) upgraded to Buy from Neutral at Guggenheim... PennyMac Mortgage (PMT) upgraded to Buy from Neutral at Compass Point... Pool Corp. (POOL) upgraded to Outperform from Market Perform at William Blair... Popular (BPOP) upgraded to Buy from Neutral at Guggenheim... Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley... Quality Systems (QSII) upgraded on valuation at RBC Capital... VF Corp. (VFC) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded on valuation, positive catalysts at BMO Capital... Weatherford (WFT) upgraded to Equal Weight from Underweight at Barclays... SS&C (SSNC) upgraded to Buy from Hold at Sandler O'Neill... Chemung Financial (CHMG) upgraded to Buy from Hold at Sandler O'Neill... Cameron (CAM) upgraded to Buy from Accumulate at Global Hunter.
08:10 EDTAETLeerink sees at least 60% chance of Anthem, Cigna deal being approved
Subscribe for More Information
07:33 EDTCNCCentene upgraded to Buy from Neutral at UBS
UBS upgraded Centene to Buy from Neutral citing recent share weakness, its strong pipeline and other underappreciated opportunities. UBS maintained its $80 price target on Centene shares.
July 26, 2015
18:22 EDTAETMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
July 22, 2015
08:47 EDTCNCCentene weakness creates buying opportunity, says BMO Capital
BMO Capital believes that Centene's (CNC) earnings can increase 24% year-over-year in the near-term, driven by predictable levels of medical cost and continued membership growth. Over the longer term, the firm thinks that the company's acquisition of HealthNet (HNT), large addressable markets, cost synergies and improved positioning in California leave it well-positioned to increase its earnings.
08:43 EDTAETAetna positioned to report good Q2 results, says BMO Capital
Subscribe for More Information
July 21, 2015
10:01 EDTCNCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:28 EDTCNCCentene downgraded to Sell from Neutral at Goldman
Goldman downgraded Centene (CNC) to Sell with a $69 price target. The firm's analyst believes Centene's acquisition of Health Net (HNT) is a signal of slower organic growth and makes the company a less likely M&A target. Goldman sees increasing execution risk given complex deal integration and lowered its price target to $69 from $73 on shares.
July 17, 2015
07:50 EDTUNHUnitedHealth, Catamaran deal will close earlier than expected, says UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use